<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02353689</url>
  </required_header>
  <id_info>
    <org_study_id>2-1040709-AB-N-01-201310-BR-03</org_study_id>
    <nct_id>NCT02353689</nct_id>
  </id_info>
  <brief_title>The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement</brief_title>
  <official_title>Identification of the Effect of Fermentable Oligo-, di-, and Mono- Saccharides and Poorly Absorbed Short-chain Carbohydrate (FODMAP) Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oh Yoen Kim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dong-A University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dong-A University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to investigate the effects of FODMAP contents in enteral nutrition (EN)
      formulas on major gastrointestinal intolerance symptoms and nutritional status in tube fed
      patients through the randomized, double blind and placebo-controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blind, placebo-controlled study was conducted on 100 tube-fed patients.
      Over a 14-day test period, the test group consumed EN formula containing low FODMAPs, while
      the placebo groups consumed EN formula containing moderate or high FODMAPs .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>diarrhea</measure>
    <time_frame>14-day follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>prealbumin</measure>
    <time_frame>14-day follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body mass index</measure>
    <time_frame>14-day follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Enteral Nutrition</condition>
  <arm_group>
    <arm_group_label>low FODMAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate FODMAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high FODMAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low FODMAP</intervention_name>
    <description>consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention</description>
    <arm_group_label>low FODMAP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>moderate FODMAP</intervention_name>
    <description>consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention</description>
    <arm_group_label>moderate FODMAP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high FODMAP</intervention_name>
    <description>consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention</description>
    <arm_group_label>high FODMAP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  tube-feeding patients

        Exclusion Criteria:

          -  EN prohibited

          -  renal dysfunction (i.e. serum creatinine &gt; 1.5 mg/dl or blood urea nitrogen &gt; 25
             mg/ml)

          -  liver dysfunction (i.e. serum aspartate aminotransferase &gt; 40 U/L or alanine
             aminotransferase &gt; 40 U/L)

          -  uncontrollable diabetes mellitus

          -  pregnancy, breast-feeding etc.

          -  severe diarrhea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oh Yoen Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dong-A Univeristy</affiliation>
  </overall_official>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2015</study_first_posted>
  <last_update_submitted>February 4, 2015</last_update_submitted>
  <last_update_submitted_qc>February 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Dong-A University</investigator_affiliation>
    <investigator_full_name>Oh Yoen Kim</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

